• Image of Trizivir medication Image of Trizivir medication
    • TRIZIVIR (Brand for ABACAVIR-LAMIVUDINE-ZIDOVUDINE)

    • QTY 60
    • 150-300 MG
    • Tablet
    • Near  75201

ABACAVIR; LAMIVUDINE; ZIDOVUDINE (a ba KA vir; la MI vyoo deen; zye DOE vyoo deen) helps manage the symptoms of HIV infection. It works by limiting the spread of HIV in the body. It is a combination of three antiretroviral medications. This medication is not a cure for HIV or AIDS and it may still be possible to spread HIV to others while taking it. It does not prevent other sexually transmitted infections (STIs).


TRIZIVIR (Brand for ABACAVIR-LAMIVUDINE-ZIDOVUDINE) Lifestyle Interactions

  • Abacavir Sulfate 300mg, Lamivudine 150mg, Zidovudine 300mg, Oral tablet

    Interaction: Alcohol
    Severity: Major
    Notes for Consumers: Do not drink alcohol while taking this medication. Drinking alcohol may alter the effects of your medication. Serious side effects may occur. Contact your care team if you experience new or worsening side effects.
    Notes for Professionals: Advise patients to avoid alcohol consumption while taking abacavir. Abacavir is metabolized via alcohol dehydrogenase. Alcohol decreases the elimination of abacavir causing an increase in overall exposure to abacavir. In a study involving HIV-infected men, coadministration of alcohol and abacavir resulted in a 41% increase in abacavir AUC and a 26% increase in abacavir half-life. In males, abacavir had no effect on the pharmacokinetic properties of alcohol; this interaction has not been studied in females. Abacavir has no effect on the pharmacokinetic properties of alcohol.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.